RNA Interference

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 10: Line 10:
*[[User:Wayne Decatur/Tomato aspermy virus protein 2b Suppression of RNA Silencing|Tomato aspermy virus protein 2b Suppression of RNA Silencing]]
*[[User:Wayne Decatur/Tomato aspermy virus protein 2b Suppression of RNA Silencing|Tomato aspermy virus protein 2b Suppression of RNA Silencing]]
<br />
<br />
 +
 +
To view automatically seeded pages concerning Influenza See:
 +
*[[:Category:Rnai|RNAi]]
 +
*[[:Category:Rnai_suppression|RNAi Suppression]]
 +
*[[:Category:Rna interference|RNA Interference]]
<br />
<br />
-
To view other Proteopedia pages about diseases & drug targets, See: [[Pharmaceutical_Drug_Targets|Pharmaceutical Drug Targets]] <br />
+
To view other Proteopedia pages about diseases & drug targets, See: [[Pharmaceutical_Drug_Targets|Pharmaceutical Drug Targets]]

Revision as of 07:28, 26 September 2010

Schematic of RNAi Interference in Mammalian Cells
Schematic of RNAi Interference in Mammalian Cells

RNA Interference (RNAi) is a system in living cells that helps control the level of activity of genes. In RNAi, a long double stranded RNA is cleaved into shorter strands. One strand known as the guide strand is complimentary to the mRNA gene product of a gene of interest. This guide strand is incorporated into an RNA-induced silencing complex (RISC) and subsequently binds the mRNA of the gene of interest. After binding, the RNA/RISC complex subsequently silences the mRNA of interest via cleavage of the mRNA strand.

Articles in Proteopedia concerning RNA Interference include:


To view automatically seeded pages concerning Influenza See:


To view other Proteopedia pages about diseases & drug targets, See: Pharmaceutical Drug Targets

Proteopedia Page Contributors and Editors (what is this?)

David Canner, Wayne Decatur, Eric Martz

Personal tools